+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Patient-Derived Xenograft/PDX Model Market by Type (Mouse, Rat), Tumor Type (Gastrointestinal, Gynecological, Hematological), Application (Preclinical Drug Development, Biomarker analysis), End User (Pharma, Biotech, CROs) - Global Forecast to 2026

  • ID: 5315029
  • Report
  • April 2021
  • Region: Global
  • 171 Pages
  • Markets and Markets
The Global Patient-Derived Xenograft/PDX Models Market Size is Projected to reach USD 299 Million by 2026 from USD 140 Million in 2021, at a CAGR of 16.4%

FEATURED COMPANIES

  • Abnova Corporation
  • Bioduro
  • Envigo
  • Explora Biolabs
  • Jsr Corporation
  • Oncodesign
  • MORE

The global Patient-Derived Xenograft/PDX models market size is projected to reach USD 299 million by 2026 from USD 140 million in 2021, at a CAGR of 16.4% during the forecast period. Market growth is driven mainly by factors such as growing demand for personalized medicine, continuous support for cancer research, and growth in pharma R&D. Rising demand for humanized PDX models is expected to provide growth opportunity for players in the PDX models market. However, the high cost of personalized PDX models, stringent guidelines regarding the ethical use of animals in cancer research, and limitations associated with PDX models are expected to restrain the growth of this market to a certain extent during the forecast period.

The preclinical drug development segment accounted for the highest growth rate in the PDX models market, by application, during the forecast period

The PDX models market is segmented into preclinical drug development, biomarker analysis, and basic cancer research. The preclinical drug development segment accounted for the highest growth rate in the PDX models market during the forecast period. This segment's high growth rate can be attributed to the rising number of clinical trials every year.

Contract research organizations segment accounted for the highest CAGR

Based on end users, the PDX models market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutions. During the forecast period contract research organizations accounted for the highest growth rate. The high growth rate in this segment can be attributed to the increasing number of pharmaceutical companies outsourcing their preclinical studies to CROs. 

Rat models segment accounted for the highest CAGR

Based on type, the PDX models market is segmented into mice models and rat models. The rat models segment accounted for the highest growth rate during the forecast period. Growth in this market is mainly driven by the larger size of rats, which enhances surgical manipulation. Moreover, the development of immunodeficient rats will further drive the usage of rat models in PDX model generation.

Respiratory tumor models segment accounted for the highest CAGR

Based on tumor type, the PDX models market is segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models. The respiratory tumor models segment accounted for the highest growth rate during the forecast period. The key factor driving this segment's growth is the increasing incidence of lung cancers globally.

Asia Pacific: The fastest-growing country in the PDX models market

The PDX models market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the PDX models market in this region. 

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply-Side- 70%, and Demand Side - 30%
  • By Designation (Supply Side): Managers - 45%, CXOs and Directors - 30%, and Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • JSR Corporation (Japan)
  • WuXi AppTec (China)
  • Champions Oncology, Inc. (US)
  • THE JACKSON LABORATORY (US)
  • Charles River Laboratories (US)
  • Oncodesign (France)
  • Envigo (US)
  • Pharmatest Services (Finland)
  • Hera BioLabs (US)
  • EPO Berlin-Buch GmbH (Germany)
  • Xentech (France)
  • Urosphere (France)
  • Abnova Corporation (Taiwan)
  • Genesis Biotechnology Group (US)
  • Explora BioLabs (US)
  • Biocytogen (US)
  • Living Tumor Laboratory (Canada)
  • Bioduro (US)
  • Aragen Life Sciences w.e.f, (US)
  • Shanghai Lide Biotech Co., Ltd. (China)

Research Coverage:

This report provides a detailed picture of the PDX models market. It aims at estimating the size and future growth potential of the market across different segments, such as type, tumor type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall PDX models market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abnova Corporation
  • Bioduro
  • Envigo
  • Explora Biolabs
  • Jsr Corporation
  • Oncodesign
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Primary Sources
Figure 3 PDX Models Market: Breakdown of Primaries
2.1.2.1 Key Industry Insights
2.2 Market Size Estimation
Figure 4 Market Size Estimation: Approach 1 - Revenue Share Analysis, 2020
Figure 5 Average Market Size Estimation, 2020
Figure 6 PDX Models Market: CAGR Projections, 2021-2026
Figure 7 PDX Models Market: Growth Analysis of Drivers, Restraints, Opportunities, and Challenges
2.3 Market Breakdown and Data Triangulation
Figure 8 Data Triangulation Methodology
2.4 Research Assumptions
2.5 Risk Analysis

3 Executive Summary
Figure 9 PDX Models Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 10 PDX Models Market, by Tumor Type, 2021 Vs. 2026 (USD Million)
Figure 11 PDX Models Market, by Application, 2021 Vs. 2026 (USD Million)
Figure 12 PDX Models Market, by End-user, 2021 Vs. 2026 (USD Million)
Figure 13 PDX Models Market: Geographic Snapshot

4 Premium Insights
4.1 PDX Models Market Overview
Figure 14 Increasing Support for Cancer Research from Public and Private Sectors and Growing Demand for Precision Medicine Are Key Growth Drivers
4.2 North America: PDX Models Market, Market Share (2020)
Figure 15 Mice Models Commanded the Largest Share of the North American PDX Models Market in 2020
4.3 PDX Models Market Share, by End-user (2020)
Figure 16 Pharmaceutical & Biotechnology Companies Commanded the Largest Share of the PDX Models Market in 2020
4.4 PDX Models Market: Geographic Growth Opportunities
Figure 17 China to Witness the Highest Growth in the PDX Models Market During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 18 PDX Models Market: Drivers, Restraints, Opportunities, and Challenges
Table 1 PDX Models Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Growing Demand for Personalized Medicine
5.2.1.2 Continuous Support for Cancer Research from the Public & Private Sectors
5.2.1.3 Rising Pharma R&D
5.2.2 Restraints
5.2.2.1 High Cost of Personalized PDX Models
5.2.2.2 Stringent Guidelines for the Use of Animal Models in Cancer Research
5.2.3 Opportunities
5.2.3.1 Rising Demand for Humanized PDX Models
5.2.4 Challenges
5.2.4.1 Limitations of PDX Models
5.3 Impact of the COVID-19 Outbreak on the Growth of the PDX Models Market
5.4 Technological Analysis
5.5 Pricing Analysis
5.6 Value Chain Analysis
Figure 19 Value Chain Analysis of PDX Models Market: R&D and Manufacturing Phases Add Maximum Value
Figure 20 Value Chain: Creation of PDX Models-Maximum Value is Added During the Implantations of Tumor Cells in Immunodeficient Mice or Rats
5.7 Ecosystem Analysis of the PDX Models Market
Figure 21 Ecosystem Analysis of the PDX Models Market
Table 2 Supply Chain Ecosystem
5.8 Porter’S Five Forces Analysis
Table 3 PDX Models Market: Porter’S Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Buyers
5.8.4 Bargaining Power of Suppliers
5.8.5 Intensity of Competitive Rivalry
5.9 Regulatory Analysis
5.9.1 North America
5.9.2 Europe
5.9.3 Asia-Pacific
5.9.3.1 China
5.9.3.2 Japan
5.9.3.3 India
5.9.3.4 Australia
5.9.4 Latin America
5.9.5 Middle East & Africa
5.10 Patent Analysis
Figure 22 Patents Granted for PDX Models, January 2010-December 2020

6 PDX Models Market, by Type
6.1 Introduction
Table 4 PDX Models Market, by Type, 2019-2026 (USD Million)
6.2 Mice Models
6.2.1 Ease of Procurement and Wide Availability of Mice Models Drive the Growth of this Segment
Table 5 PDX Mice Models Market, by Region, 2019-2026 (USD Million)
Table 6 North America: PDX Mice Models Market, by Country, 2019-2026 (USD Million)
Table 7 Europe: PDX Mice Models Market, by Country, 2019-2026 (USD Million)
Table 8 Asia-Pacific: PDX Mice Models Market, by Country, 2019-2026 (USD Million)
6.3 Rat Models
6.3.1 Factors Such as Easier Surgical Manipulation and Larger Tumor Size Will Support Use of Rat Models
Table 9 PDX Rat Models Market, by Region, 2019-2026 (USD Million)
Table 10 North America: PDX Rat Models Market, by Country, 2019-2026 (USD Million)
Table 11 Europe: PDX Rat Models Market, by Country, 2019-2026 (USD Million)
Table 12 Asia-Pacific: PDX Rat Models Market, by Country, 2019-2026 (USD Million)

7 PDX Models Market, by Tumor Type
7.1 Introduction
Table 13 PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
7.2 Gastrointestinal Tumor Models
7.2.1 Newly Developed Gastrointestinal Tumor Models Mimic the Tumor Better Than Previous Models
Table 14 Gastrointestinal Tumor Models Market, by Region, 2019-2026 (USD Million)
Table 15 North America: Gastrointestinal Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 16 Europe: Gastrointestinal Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 17 Asia-Pacific: Gastrointestinal Tumor Models Market, by Country, 2019-2026 (USD Million)
7.3 Gynecological Tumor Models
7.3.1 High Incidence of Target Cancers Has Driven Demand for Tumor Models
Table 18 Gynecological Tumor Models Market, by Region, 2019-2026 (USD Million)
Table 19 North America: Gynecological Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 20 Europe: Gynecological Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 21 Asia-Pacific: Gynecological Tumor Models Market, by Country, 2019-2026 (USD Million)
7.4 Respiratory Tumor Models
7.4.1 Rising Prevalence of Lung Cancer to Drive Market Growth
Table 22 Respiratory Tumor Models Market, by Region, 2019-2026 (USD Million)
Table 23 North America: Respiratory Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 24 Europe: Respiratory Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 25 Asia-Pacific: Respiratory Tumor Models Market, by Country, 2019-2026 (USD Million)
7.5 Urological Tumor Models
7.5.1 Companies Are Focusing on Expanding Their Portfolio for Urological Cancers
Table 26 Urological Tumor Models Market, by Region, 2019-2026 (USD Million)
Table 27 North America: Urological Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 28 Europe: Urological Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 29 Asia-Pacific: Urological Tumor Models Market, by Country, 2019-2026 (USD Million)
7.6 Hematological Tumor Models
7.6.1 New Strains Such as Nsg and Nog Have Increased the Life Span of Hematological Tumor Models
Table 30 Hematological Tumor Models Market, by Region, 2019-2026 (USD Million)
Table 31 North America: Hematological Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 32 Europe: Hematological Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 33 Asia-Pacific: Hematological Tumor Models Market, by Country, 2019-2026 (USD Million)
7.7 Other Tumor Models
Table 34 Other Tumor Models Market, by Region, 2019-2026 (USD Million)
Table 35 North America: Other Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 36 Europe: Other Tumor Models Market, by Country, 2019-2026 (USD Million)
Table 37 Asia-Pacific: Other Tumor Models Market, by Country, 2019-2026 (USD Million)

8 PDX Models Market, by Application
8.1 Introduction
Table 38 PDX Models Market, by Application, 2021-2026 (USD Million)
8.2 Preclinical Drug Development
8.2.1 Rise in Number of Clinical Trials Will Drive the Growth of this Segment
Table 39 PDX Models Market for Preclinical Drug Development, by Region, 2019-2026 (USD Million)
Table 40 North America: PDX Models Market for Preclinical Drug Development, by Country, 2019-2026 (USD Million)
Table 41 Europe: PDX Models Market for Preclinical Drug Development, by Country, 2019-2026 (USD Million)
Table 42 Asia-Pacific: PDX Models Market for Preclinical Drug Development, by Country, 2019-2026 (USD Million)
8.3 Biomarker Analysis
8.3.1 Growing Interest in Precision Medicine Will Contribute to the Demand for PDX Models for Biomarker Analysis
Table 43 PDX Models Market for Biomarker Analysis, by Region, 2019-2026 (USD Million)
Table 44 North America: PDX Models Market for Biomarker Analysis, by Country, 2019-2026 (USD Million)
Table 45 Europe: PDX Models Market for Biomarker Analysis, by Country, 2019-2026 (USD Million)
Table 46 Asia-Pacific: PDX Models Market for Biomarker Analysis, by Country, 2019-2026 (USD Million)
8.4 Basic Cancer Research
8.4.1 Rising Funding for Cancer Research Will Drive Market Growth in this Segment
Table 47 PDX Models Market for Basic Cancer Research, by Region, 2019-2026 (USD Million)
Table 48 North America: PDX Models Market for Basic Cancer Research, by Country, 2019-2026 (USD Million)
Table 49 Europe: PDX Models Market for Basic Cancer Research, by Country, 2019-2026 (USD Million)
Table 50 Asia-Pacific: PDX Models Market for Basic Cancer Research, by Country, 2019-2026 (USD Million)

9 PDX Models Market, by End-user
9.1 Introduction
Table 51 PDX Models Market, by End-user, 2019-2026 (USD Million)
9.2 Pharmaceutical & Biotechnology Companies
9.2.1 Rising Collaboration Between Pharma & Biotech Companies for Developing Cancer Therapeutics
Table 52 PDX Models Market for Pharmaceutical & Biotechnology Companies, by Region, 2019-2026 (USD Million)
Table 53 North America: PDX Models Market for Pharmaceutical and Biotechnology Companies, by Country, 2019-2026 (USD Million)
Table 54 Europe: PDX Models Market for Pharmaceutical and Biotechnology Companies, by Country, 2019-2026 (USD Million)
Table 55 Asia-Pacific: PDX Models Market for Pharmaceutical and Biotechnology Companies, by Country, 2019-2026 (USD Million)
9.3 Contract Research Organizations
9.3.1 Rising Outsourcing of Drug Discovery Services Will Drive Market Growth
Table 56 PDX Models Market for Contract Research Organizations, by Region, 2019-2026 (USD Million)
Table 57 North America: PDX Models Market for Contract Research Organizations, by Country, 2019-2026 (USD Million)
Table 58 Europe: PDX Models Market for Contract Research Organizations, by Country, 2019-2026 (USD Million)
Table 59 Asia-Pacific: PDX Models Market for Contract Research Organizations, by Country, 2019-2026 (USD Million)
9.4 Academic & Research Institutions
9.4.1 Increase in Government Life Sciences R&D Expenditure Will Contribute to the Growth of this Segment
Table 60 PDX Models Market for Academic & Research Institutions, by Region, 2019-2026 (USD Million)
Table 61 North America: PDX Models Market for Academic & Research Institutions, by Country, 2019-2026 (USD Million)
Table 62 Europe: PDX Models Market for Academic & Research Institutions, by Country, 2019-2026 (USD Million)
Table 63 Asia-Pacific: PDX Models Market for Academic & Research Institutions, by Country, 2019-2026 (USD Million)

10 PDX Models Market, by Region
10.2 North America
Table 64 PDX Models Market, by Region, 2019-2026 (USD Million)
10.2 North America
Figure 23 North America: PDX Models Market Snapshot
Table 65 North America: PDX Models Market, by Country, 2019-2026 (USD Million)
Table 66 North America: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 67 North America: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 68 North America: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 69 North America: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.2.1 US
10.2.1.1 Growing Focus on Cancer Research in the US Will Drive Market Growth
Table 70 US: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 71 US: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 72 US: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 73 US: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.2.2 Canada
10.2.2.1 Growth in Canada Can be Attributed to Rising Funding for Stem Cell Research in the Country
Table 74 Canada: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 75 Canada: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 76 Canada: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 77 Canada: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.3 Europe
Table 78 Europe: PDX Models Market, by Country/Region, 2019-2026 (USD Million)
Table 79 Europe: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 80 Europe: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 81 Europe: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 82 Europe: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.3.1 Germany
10.3.1.1 Government Funding for Life Science R&D and Basic Cancer Research Will Drive Market Growth
Table 83 Germany: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 84 Germany: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 85 Germany: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 86 Germany: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.3.2 UK
10.3.2.1 The Rising Incidence of Cancer Cases Will Lead to An Increase in Cancer Research, Which Will Drive Market Growth
Table 87 UK: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 88 UK: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 89 UK: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 90 UK: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.3.3 France
10.3.3.1 Increasing Government Funding for Cancer Research
Table 91 France: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 92 France: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 93 France: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 94 France: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.3.4 RoE
Table 95 RoE: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 96 RoE: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 97 RoE: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 98 RoE: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.4 Asia-Pacific
Figure 24 Asia-Pacific: PDX Models Market Snapshot
Table 99 Asia-Pacific: PDX Models Market, by Country, 2019-2026 (USD Million)
Table 100 Asia-Pacific: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 101 Asia-Pacific: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 102 Asia-Pacific: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 103 Asia-Pacific: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.4.1 China
10.4.1.1 The Growing Pharmaceutical Industry and Rising Number of Cros in the Country Will Drive Market Growth
Table 104 China: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 105 China: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 106 China: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 107 China: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.4.2 Japan
10.4.2.1 Research Collaborations and Growing Geriatric Population-Key Growth Drivers in Japan
Table 108 Japan: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 109 Japan: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 110 Japan: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 111 Japan: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.4.3 Rest of Asia-Pacific
Table 112 Roapac: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 113 Roapac: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 114 Roapac: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 115 Roapac: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.5 Latin America
10.5.1 Rising Pharmaceutical R&D Expenditure in the Region Will Drive the Growth of the Market
Table 116 Latin America: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 117 Latin America: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 118 Latin America: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 119 Latin America: PDX Models Market, by End-user, 2019-2026 (USD Million)
10.6 Middle East & Africa
10.6.1 Market Growth Driven by Changing Demographics and Favorable Policies for Pharma R&D
Table 120 Middle East and Africa: PDX Models Market, by Type, 2019-2026 (USD Million)
Table 121 Middle East and Africa: PDX Models Market, by Tumor Type, 2019-2026 (USD Million)
Table 122 Middle East and Africa: PDX Models Market, by Application, 2019-2026 (USD Million)
Table 123 Middle East and Africa: PDX Models Market, by End-user, 2019-2026 (USD Million)

11 Competitive Landscape
11.1 Overview
11.2 Market Evaluation Framework
Table 124 Market Evaluation Framework: Partnerships, Agreements, Joint Ventures, and Collaborations-The Major Strategies Adopted by Players
11.3 Market Share Analysis
Figure 25 PDX Models Market Share Analysis, by Key Player, 2020
11.4 Revenue Share Analysis of Top Market Players
Figure 26 Top Market Players Dominate the PDX Models Market
11.5 Company Evaluation Quadrant
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive
11.5.4 Emerging Companies
Figure 27 PDX Models Market: Company Evaluation Quadrant, 2020
11.6 Company Evaluation Quadrant: Start-Ups/SMEs
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
Figure 28 PDX Models Market: Company Evaluation Quadrant for Start-Ups/SMEs, 2020
11.7 Company Product Footprint
Table 125 Product Portfolio Analysis: PDX Models Market (2020)
11.8 Company Geographic Footprint
Table 126 Geographic Revenue Mix: PDX Models Market (2020)
11.9 Competitive Scenario
11.9.1 PDX Models Market: Product & Service Launches, January 2018-February 2021
11.9.2 PDX Models Market: Deals, January 2019-February 2021
11.9.3 PDX Models Market: Other Developments, January 2018-February 2021

12 Company Profiles
Business Overview, Products Offered, Recent Developments, SWOT Analysis, Analyst's View
12.1 Key Market Players
12.1.1 Jsr Corporation
Figure 29 Jsr Corporation: Company Snapshot (2019)
12.1.2 Wuxi Apptec
Figure 30 Wuxi Apptec: Company Snapshot (2020)
12.1.3 The Jackson Laboratory
Figure 31 The Jackson Laboratory: Company Snapshot (2019)
12.1.4 Charles River Laboratories
Figure 32 Charles River Laboratories: Company Snapshot (2020)
12.1.5 Champions Oncology
Figure 33 Champions Oncology: Company Snapshot (2020)
12.1.6 Oncodesign
Figure 34 Oncodesign: Company Snapshot (2020)
12.1.7 Envigo
12.1.8 Pharmatest Services
12.1.9 Hera Biolabs
12.1.10 EPO Berlin-Buch Gmbh
12.1.11 Xentech
12.1.12 Urosphere
12.2 Other Players
12.2.1 Abnova Corporation
12.2.2 Genesis Biotechnology Group
12.2.3 Explora Biolabs
12.2.4 Biocytogen
12.2.5 Living Tumor Laboratory
12.2.6 Bioduro
12.2.7 Aragen Life Sciences W.E.F
12.2.8 Shanghai Lide Biotech
Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, Analyst's View Might Not be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

Note: Product cover images may vary from those shown
  • Abnova Corporation
  • Aragen Life Sciences W.E.F
  • Biocytogen
  • Bioduro
  • Champions Oncology
  • Charles River Laboratories
  • Envigo
  • EPO Berlin-Buch Gmbh
  • Explora Biolabs
  • Genesis Biotechnology Group
  • Hera Biolabs
  • Jsr Corporation
  • Living Tumor Laboratory
  • Oncodesign
  • Pharmatest Services
  • Shanghai Lide Biotech
  • The Jackson Laboratory
  • Urosphere
  • Wuxi Apptec
  • Xentech
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll